{"id":"nomegestrol-acetate-estradiol","safety":{"commonSideEffects":[{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Breast tenderness"},{"rate":null,"effect":"Breakthrough bleeding"},{"rate":null,"effect":"Venous thromboembolism"}]},"_chembl":{"chemblId":"CHEMBL1476022","moleculeType":"Small molecule","molecularWeight":"370.49"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Nomegestrol acetate is a progestin that inhibits the luteinizing hormone (LH) surge necessary for ovulation, while estradiol (a natural estrogen) provides cycle control and endometrial stability. Together, they create a combined oral contraceptive formulation that prevents pregnancy through multiple mechanisms including ovulation suppression, cervical mucus thickening, and endometrial atrophy.","oneSentence":"Nomegestrol acetate and estradiol work together as a hormonal contraceptive by suppressing ovulation through progestin and estrogen activity.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:57:27.857Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Contraception in women of reproductive age"}]},"trialDetails":[{"nctId":"NCT05264506","phase":"PHASE3","title":"Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2022-02-17","conditions":"Contraception","enrollment":3055},{"nctId":"NCT02636972","phase":"","title":"The Progression From Dysmenorrhoea to Chronic Pelvic Pain","status":"COMPLETED","sponsor":"University of Adelaide","startDate":"2014-11","conditions":"Dysmenorrhoea, Pelvic Pain, Chronic Pain","enrollment":56},{"nctId":"NCT01656434","phase":"PHASE3","title":"Study of the Contraceptive Efficacy and Safety of a NOMAC-E2 Combined Oral Contraceptive (COC)(P06448)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2012-11-02","conditions":"Contraception","enrollment":3173},{"nctId":"NCT01709318","phase":"PHASE2","title":"A Dose-Finding Study to Evaluate Ovarian Function and Vaginal Bleeding in Next Generation Rings (P06109/MK-8175A/MK-8342B-012)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2012-12-12","conditions":"Contraception","enrollment":666},{"nctId":"NCT01670656","phase":"PHASE2","title":"A Study to Evaluate the Effect of Contraceptive Vaginal Rings on Primary Dysmenorrhea (P08257/MK-8175A/MK-8342B-057)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2013-01-21","conditions":"Dysmenorrhea","enrollment":439},{"nctId":"NCT06324851","phase":"PHASE4","title":"The Use of Drospirenone/Estetrol, Nomegestrol Acetate/Estradiol and Ethinylestradiol/Dienogest in Random Start Rapid Endometrial Preparation","status":"COMPLETED","sponsor":"University of Palermo","startDate":"2023-01-01","conditions":"Endometrial Polyp, Endometrial Diseases","enrollment":150},{"nctId":"NCT06316219","phase":"PHASE4","title":"The Use of Nomegestrol Acetate/Estradiol in Random Start Rapid Endometrial Preparation","status":"COMPLETED","sponsor":"University of Palermo","startDate":"2023-01-01","conditions":"Endometrial Polyp, Endometrial Diseases","enrollment":80},{"nctId":"NCT01723579","phase":"PHASE3","title":"Efficacy and Safety of Oral NOMAC-E2 in Indian Women (P07057/MK-8175A-017)","status":"WITHDRAWN","sponsor":"Organon and Co","startDate":"2013-07","conditions":"Contraception","enrollment":""},{"nctId":"NCT01345786","phase":"PHASE1","title":"Bioequivalence of Nomegestrol Acetate (NOMAC) and Estradiol (E2) in Commercial Versus Phase 3 Pivotal Clinical Batches of NOMAC-E2 Tablets (P06328)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2009-11","conditions":"Healthy Postmenopausal Females","enrollment":158},{"nctId":"NCT00413062","phase":"PHASE3","title":"Efficacy and Safety Study of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292002)(P05722)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-06","conditions":"Contraception","enrollment":2281},{"nctId":"NCT00511355","phase":"PHASE3","title":"Effects on Hemostasis, Lipids, Carbohydrate Metabolism, Adrenal & Thyroid Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG-EE (292004)(COMPLETED)(P05764)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-10","conditions":"Contraception","enrollment":121},{"nctId":"NCT00511342","phase":"PHASE3","title":"Effects on Bone Mineral Density (BMD) of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG/EE (292005)(P05765)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-09","conditions":"Contraception","enrollment":110},{"nctId":"NCT00511433","phase":"PHASE3","title":"Effects on Ovarian Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292003)(COMPLETED)(P05723)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-10","conditions":"Contraception","enrollment":48},{"nctId":"NCT00511199","phase":"PHASE3","title":"Efficacy and Safety of the Combined Oral Contraceptive (COC) NOMAC-E2 Compared to a COC Containing DRSP/EE (292001)(COMPLETED)(P05724)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-05-01","conditions":"Contraception","enrollment":2152},{"nctId":"NCT00711607","phase":"PHASE1","title":"A Trial to Assess the Pharmacokinetic Profile (e.g., Uptake, Distribution and Excretion of a Substance in the Body) of Nomegestrol Acetate (NOMAC), Estradiol (E2) and Estrone (E1) After Multiple and Single Dose Administration of the Combined Oral Contraception NOMAC-E2 (COMPLETED)(P05822)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-05-01","conditions":"Healthy","enrollment":25},{"nctId":"NCT01650168","phase":"","title":"Prospective Controlled Cohort Study on the Safety of a Monophasic Oral Contraceptive Containing Nomegestrol Acetate (2.5mg) and 17ß-estradiol (1.5mg)","status":"COMPLETED","sponsor":"Center for Epidemiology and Health Research, Germany","startDate":"2012-07","conditions":"Contraception","enrollment":101498},{"nctId":"NCT03749733","phase":"PHASE1","title":"Bioequivalence of Two Fixed-dose Combination Tablets Containing Estradiol and Nomegestrol Acetate","status":"WITHDRAWN","sponsor":"Grünenthal GmbH","startDate":"2019-10","conditions":"Bioequivalence","enrollment":""},{"nctId":"NCT03531437","phase":"PHASE4","title":"Comparison of Coagulation Profiles Between Zoely and Minidoz: RCT","status":"TERMINATED","sponsor":"Mahidol University","startDate":"2016-03","conditions":"Contraception, Hypercoagulability","enrollment":112},{"nctId":"NCT03077555","phase":"PHASE4","title":"Ovulation and Follicular Development Associated With Mid Follicular Phase Initiation of Combined Hormonal Contraception","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2017-01-21","conditions":"Ovulation Inhibition","enrollment":69},{"nctId":"NCT00127075","phase":"PHASE3","title":"POPART'MUS: Prevention of Post Partum Relapses With Progestin and Estradiol in Multiple Sclerosis","status":"UNKNOWN","sponsor":"Hospices Civils de Lyon","startDate":"2005-06","conditions":"Multiple Sclerosis","enrollment":300},{"nctId":"NCT01361958","phase":"PHASE2","title":"Minimal Effective Dose of Nomegestrol Acetate Inhibiting the Ovulation in Women Receiving Estradiol","status":"COMPLETED","sponsor":"Theramex","startDate":"1997-02","conditions":"Suppression of Ovulation","enrollment":38}],"_emaApprovals":[],"_faersSignals":[{"count":2,"reaction":"DEEP VEIN THROMBOSIS"},{"count":2,"reaction":"URTICARIA"},{"count":1,"reaction":"ACNE"},{"count":1,"reaction":"ALOPECIA"},{"count":1,"reaction":"DEPRESSION"},{"count":1,"reaction":"DIZZINESS"},{"count":1,"reaction":"ECTOPIC PREGNANCY"},{"count":1,"reaction":"HYPERSENSITIVITY"},{"count":1,"reaction":"LIGAMENT RUPTURE"},{"count":1,"reaction":"NAUSEA"}],"_approvalHistory":[],"publicationCount":5,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Nomegestrol Acetate / Estradiol","genericName":"Nomegestrol Acetate / Estradiol","companyName":"University of Palermo","companyId":"university-of-palermo","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Nomegestrol acetate and estradiol work together as a hormonal contraceptive by suppressing ovulation through progestin and estrogen activity. Used for Contraception in women of reproductive age.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}